vicagrel + omeprazole

Vicagrel + omeprazole is a combination of two pharmaceutical agents. Vicagrel is a novel acetate derivative of clopidogrel and acts as an antiplatelet agent by irreversibly inhibiting the P2Y12 receptor on platelets. This mechanism prevents platelet aggregation and reduces the risk of thrombotic events. Omeprazole is a proton pump inhibitor (PPI) that decreases gastric acid secretion by irreversibly inhibiting the H+/K+-ATPase enzyme system in gastric parietal cells. It is used to treat conditions such as gastroesophageal reflux disease (GERD), peptic ulcers, and Zollinger-Ellison syndrome[1][2][3][4][6]. The combination may be considered in patients requiring both antiplatelet therapy and acid suppression; however, pharmacokinetic interactions between PPIs like omeprazole and thienopyridine antiplatelets are clinically relevant due to shared metabolic pathways[5].

Brand names

KonvomepOmeclamoxPrevidolrx Analgesic PakTaliciaYosprala